Inaccuracy of doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: Implications for clinical practice

Chest

Volumn 139, Issue 5, 2011, Pages 988-993

  Rich, Jonathan D ^a   Shah, Sanjiv J ^b   Swamy, Rajiv S ^a   Kamp, Anna ^c   Rich, Stuart ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; INTERMETHOD COMPARISON; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SARCOIDOSIS; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; TRICUSPID VALVE REGURGITATION;

EID: 79955785234     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-1269     Document Type: Article

References (30)

1. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007;30(6):1103-1110.
2. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-349.
3. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation. 2002;106(12):1477-1482.
4. McLaughlin VV, Archer SL, Badesch DB, et al; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250-2294.
5. Galiè N, Hoeper MM, Humbert M, et al; Authors/Task Force Members;ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30(20):2493-2537.
6. National Institutes of Health Clinical Center. Pulmonary hypertension, hypoxia and sickle cell disease. NCT00495638. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2007. http://clinicaltrials.gov/ct2/show/ NCT00495638. Updated March 5, 2011.
7. Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6(2):359-365. (Pubitemid 15048812)
8. Hecht SR, Berger M, Berdoff RL, Van Tosh A, Stimola JM. Use of continuous-wave Doppler ultrasound to evaluate and manage primary pulmonary hypertension. Chest. 1986;90(5):781-783. (Pubitemid 17181665)
9. Selimovic N, Rundqvist B, Bergh CH, et al. Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2007;26(9):927-934. (Pubitemid 47369201)
10. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615-621.
11. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167(5):735-740. (Pubitemid 36801751)
12. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006;44(6):1502-1510. (Pubitemid 44953655)
13. Rich S, D'Alonzo GE, Dantzker DR, Levy PS. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. Am J Cardiol. 1985;55(1):159-163. (Pubitemid 15152542)
14. Lang RM, Bierig M, Devereux RB, et al; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-1463. (Pubitemid 41821197)
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310. (Pubitemid 16134762)
16. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70(4):657-662. (Pubitemid 14020664)
17. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler- catheterization study in 127 patients. J Am Coll Cardiol. 1985;6(4):750-756. (Pubitemid 16247620)
18. Sastry BK, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43(7):1149-1153. (Pubitemid 38452588)
19. Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J. 2005;26(5):858-863. (Pubitemid 41632043)
20. Abenhaim L, Moride Y, Brenot F, et al; International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335(9):609-616. (Pubitemid 26277950)
21. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030.
22. Merrill C, Nagamine M, Elixhauser A. Hospital Stays Involving Pulmonary Heart Disease, 2005. HCUP Statistical Brief #43. Rockville, MD: Agency for Health Care Research and Quality; 2007.
23. Minai OA, Nathan SD, Hill NS, Badesch DB, Stoller JK. Pulmonary hypertension in lung diseases: Survey of beliefs and practice patterns. Respir Med. 2010;104(5):741-748.
24. Rich S. The current treatment of pulmonary arterial hypertension: time to redefine success. Chest. 2006;130(4):1198-1202. (Pubitemid 44583753)
25. Highland KB, Strange C, Mazur J, Simpson KN. Treatment of pulmonary arterial hypertension: a preliminary decision analysis. Chest. 2003;124(6):2087-2092. (Pubitemid 38010573)
26. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387.
27. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9):e283.
28. Brennan JM, Blair JE, Goonewardena S, et al. Reappraisal of the use of inferior vena cava for estimating right atrial pressure. J Am Soc Echocardiogr. 2007;20(7):857-861. (Pubitemid 47016906)
29. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39(7):1214-1219. (Pubitemid 34267428)
30. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):40S-47S.